Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to -$0.05.

  • Rockwell Medical's EPS (Basic) fell 20000.0% to -$0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.18, marking a year-over-year decrease of 26000.0%. This contributed to the annual value of -$0.02 for FY2024, which is 9517.91% up from last year.
  • Rockwell Medical's EPS (Basic) amounted to -$0.05 in Q3 2025, which was down 20000.0% from -$0.05 recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's EPS (Basic) peaked at $0.05 during Q3 2024, and registered a low of -$1.04 during Q4 2021.
  • Over the past 5 years, Rockwell Medical's median EPS (Basic) value was -$0.07 (recorded in 2023), while the average stood at -$0.31.
  • In the last 5 years, Rockwell Medical's EPS (Basic) plummeted by 105555.56% in 2021 and then skyrocketed by 17142.86% in 2024.
  • Over the past 5 years, Rockwell Medical's EPS (Basic) (Quarter) stood at -$1.04 in 2021, then surged by 95.19% to -$0.05 in 2022, then grew by 0.0% to -$0.05 in 2023, then soared by 49.84% to -$0.03 in 2024, then tumbled by 99.35% to -$0.05 in 2025.
  • Its EPS (Basic) stands at -$0.05 for Q3 2025, versus -$0.05 for Q2 2025 and -$0.04 for Q1 2025.